Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Cryotherapy and compression therapy might help prevent chemotherapy nerve damage, but more research is needed.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

A blood pressure drug, diltiazem, may also help treat influenza.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

No treatment fully prevents hair loss from chemotherapy yet.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

SIG-1451 could be a promising new treatment for atopic dermatitis.

New treatments for alopecia areata show promise in improving hair loss outcomes.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.